Treatment of chronic wounds with methylene blue photodynamic therapy: A case report (2022)

Peer-Reviewed Study · Cesar GB; Winyk AP; Sluchensci Dos Santos F; Queiroz EF; Soares KCN; Caetano W; Tominaga TT · July 14, 2022

Cesar GB et al., 2022-07-14: Brazilian case report on complex chronic wounds larger than 40 cm2 (diabetic foot, venous leg, pressure ulcers) treated weekly with 1% aqueous methylene blue and a 660 nm LED at 3.8 J/cm2: wound size fell and infection signs (odour, exudate, pus) decreased with no adverse effects.

Once a week, patients had an aqueous formulation of MB at a concentration of 10 mg/mL (1% w/v) applied topically on their wounds, which were then irradiated with a light-emitting diode (LED) light source (660 nm, 3.8 J/cm2) with 9 mW/cm2 on tissue surface.

Abstract

Cesar GB et al., 2022-07-14: Brazilian case report on complex chronic wounds larger than 40 cm2 (diabetic foot, venous leg, pressure ulcers) treated weekly with 1% aqueous methylene blue and a 660 nm LED at 3.8 J/cm2: wound size fell and infection signs (odour, exudate, pus) decreased with no adverse effects. Study type: case report/series (patients with wounds >40 cm2, low healing potential). Country: Brazil (Universidade Estadual de Ponta Grossa / Londrina). MB 10 mg/mL (1% w/v) aqueous, topical, weekly; LED 660 nm, 3.8 J/cm2, 9 mW/cm2. Follow-up 2018-2021. Funder/COI not stated in retrieved abstract record. Patient-level observation, not a trial. Study type: case report.